FOI release
2996526 FOI Request re. qualified signatories
Some or all of the information requested may not have been provided because we determined that the request was vexatious.
Case reference FOI2025/01288
Received 9 December 2025
Published 29 January 2026
Request
We refer to paragraph 4.4 of MHRA's Blue Guide on Advertising and Promotion of Medicines in the UK which asks companies to inform the MHRA (Advertising Standards and Outreach Unit, Vigilance and Risk Management of Medicines Division) of the appointment of, and any subsequent changes to, their qualified signatories to certify advertising material. For each company listed below, please provide (1) the number of qualified signatories who are registered medical practitioners or pharmacists registered in the UK; and (2) the number of other appropriately qualified persons (AQPs), that have been notified to the MHRA as qualified signatories to certify advertising material: 1. AbbVie Limited 2. Amgen Limited 3. AstraZeneca Plc 4. Bayer Plc 5. Boehringer Ingelheim Limited 6. Bristol-Myers Squibb Pharmaceuticals Limited 7. Eli Lilly and Company Limited 8. Fresenius Medical Care (UK) Limited 9. Gilead Sciences 10. GlaxoSmithKline Plc 11. Johnson & Johnson Innovative Medicine 12. Merck 13. MSD 14. Novartis Pharmaceuticals UK Limited 15. Novo Nordisk Limited 16. Pfizer Limited 17. Roche 18. Sanofi Limited 19. Takeda UK Limited 20. CSL Behring UK Ltd
Response
See attached
Documents
This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.